Tocilizumab
4 results
Applied filters
The licence and supporting evidence for tocilizumab biosimilar
1 September 2025One licensed tocilizumab biosimilar is available: Tyenne. Learn about the licensed indications, supporting evidence and key differences.
Good governance when implementing tocilizumab biosimilar
1 August 2025Governance should consider processes for approval, procurement and supply, prescribing and administration, monitoring, and pharmacovigilance.
Preparing to use tocilizumab biosimilar
1 August 2025Introducing biosimilar tocilizumab needs planning. Work with the multidisciplinary team to ensure familiarity with the area and develop an implementation plan.
Managing COVID-19 and breastfeeding
1 May 2025Continue breastfeeding during COVID-19 infection, even if dexamethasone, Paxlovid, sotrovimab or tocilzumab are required. COVID-19 vaccines can also be given.